DUSP1 is a upregulated DDM DEG for both DFP treatment of MDA-MB-231 cells and JIB-04 treatment of MCF-7 cells, whereas its average expression in breast cancers is more than 2-fold reduced as compared to normal breast tissues (Figure 7). Here, DUSP1 is linked to breast cancer.